TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BVGBWW93
Issuer Name
ASSURA PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
NWI Thames Acquisition LP
City of registered office (if applicable)
Castle Street
Country of registered office (if applicable)
Jersey
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
08-Aug-2024
6. Date on which Issuer notified
08-Aug-2024
7. Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
| Resulting situation on the date on which threshold was crossed or reached | 7.578000 | 0.000000 | 7.578000 | 245298262 |
| Position of previous notification (if applicable) | | | | |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
| Ordinary | 245298262 | | 7.578000 | |
| Sub Total 8.A | 245298262 | 7.578000% | ||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
| Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
|
| | | | |
| Sub Total 8.B1 | | | | |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
| Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
|
| | | | | |
| Sub Total 8.B2 | | | | ||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
| Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
| NorthWest Healthcare Properties REIT | 2376599 Ontario Limited | 100.000000 | | 100.000000% |
| NorthWest Healthcare Properties REIT | NorthWest Operating Trust | 99.940000 | | 99.940000% |
| NorthWest Healthcare Properties REIT | NHP Holdings Limited Partnership | 86.300000 | | 86.300000% |
| 2376599 Ontario Limited | NorthWest Operating Trust | 0.060000 | | 0.060000% |
| NorthWest Operating Trust | NHP Holdings Limited Partnership | 13.700000 | | 13.700000% |
| NHP Holdings Limited Partnership | Healthcare Properties LP | 100.000000 | | 100.000000% |
| Healthcare Properties LP | NorthWest Healthcare Properties Corporation | 100.000000 | | 100.000000% |
| NorthWest Healthcare Properties Corporation | NWI Jersey Subco Ltd | 100.000000 | | 100.000000% |
| NWI Jersey Subco Ltd | NWI Thames Acquistion LP | 0.001000 | | 0.001000% |
| NorthWest Healthcare Properties Corporation | NWI Thames Acquistion LP | 99.999000 | | 99.999000% |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
12-Aug-2024
13. Place Of Completion
Jersey
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
